Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer’s Disease: Stereochemistry and Biological Activity-Reference-Cited by-同舟云学术

Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer’s Disease: Stereochemistry and Biological Activity

Published:2018-06-26 Issue:2 Volume:10 Page:996-1007
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Hu Xiao-Long¹,Guo Cui¹,Hou Ji-Qin¹,Feng Jia-Hao¹,Zhang Xiao-Qi²,Xiong Fei³,Ye Wen-Cai²,Wang Hao¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy. China Pharmaceutical University, Nanjing 210009, People’s Republic of China

2. Institute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou 510632, People’s Republic of China

3. State Key Laboratory of Bioelectronics, Jiangsu Laboratory for Biomaterials and Devices, Southeast University, Nanjing 210009, People’s Republic of China

Funder

Government of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00252

Reference42 articles.

1. The GSK3 hypothesis of Alzheimer’s disease

2. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease